Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Twist Bioscience (TWST)

NASDAQ: TWST · Biotechnology · South San Francisco, CA

Our rating: Neutral

Call changed from Cautious to Neutral at $112.00, low conviction, November 17, 2026.

Breaks if: The Neutral call turns Cautious if FCF burn widens beyond $130 million on a trailing twelve-month basis in either of the next two annual filings, signaling that cash discipline at this market cap is breaking down. It turns Positive if FCF loss narrows below $30 million on a trailing twelve-month basis within four quarters, putting a credible path to cash-flow breakeven in view. On price, a drawdown of 30 percent or more over the next year without a commensurate negative revision to the fundamental picture would also bring the call under review — that magnitude of de-rating would suggest the market has found a reason to reprice the growth premium that the current filings do not yet reveal.

Key figures

Market value$7.0B
Revenue, last 12 months$459M
Net income, last 12 months−$130M
Free cash flow, last 12 months−$89M
Price to earningsn/a
Free cash flow yield−1.3%
Dividend yield0.0%
Operating margin−30.4%
Return on equity−19.1%
Beta to the S&P 5002.17
Volatility, annualized73.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$127M27.9%$-0.30−$20M
June 30, 2026$118M23.2%$-0.56−$9M
March 31, 2026$111M19.3%$-0.71−$25M
December 31, 2025$104M16.9%$-0.50−$35M
September 30, 2025$99M16.9%$-0.45−$24M
June 30, 2025$96M17.9%$0.33−$11M
March 31, 2025$93M23.2%$-0.66−$17M
December 31, 2024$89M24.1%$-0.53−$24M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

58 ledger entries and 10 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.